Abstract
The role of non-drug strategies in reducing the risk of cardiovascular complications in women with metabolic syndrome during the menopausal transition
Highlights
The biological process of extinction of reproductive function is associated with the deterioration of physical and mental health, social maladaptation and a decrease in the quality of life of women [1,2]
In patients with mild menopausal syndrome (MPS), when using programs with physiotherapy, HOMA-insulin resistance (IR) decreased by 50%, the atherogenic index by more than 25%, the INR level increased by more than 4,0%, the total Green score decreased by more than 40,0%. in patients with moderate MPS, the treatment complex with the simultaneous use of vibrotherapy, chromotherapy, melootherapy, aromatherapy and aeroionotherapy had the advantage: HOMA-IR decreased by 50,5%, atherogenic index by 30,5%, INR increased by 5,0%, overall score on the Green scale decreased by 40,0%
In patients with MPS and metabolic syndrome (MS), non-drug programs using physical therapy have a positive effect on the functioning of the endocrine system, hemostasis, carbohydrate and fat metabolism which helps reduce the risk of cardiovascular events
Summary
The biological process of extinction of reproductive function is associated with the deterioration of physical and mental health, social maladaptation and a decrease in the quality of life of women [1,2]. Menopause is a predictor of MS and a high risk of cardiovascular complications [3,4]. An important role in increasing cardiovascular risk is played by thyroid dysfunction, the frequency of which increases in the menopause [5,6]. It is convincingly shown that obesity is a chronic systemic inflammation that triggers insulin resistance (IR), multi-organ metabolic dysfunction, platelet activation, and endothelial stress, which determines a high risk of cardiovascular complications [12,13,14,15,16]. The dominant role of menopausal hormone therapy (MGT) in the treatment of pathological menopause has been established [19,20], but its metabolic and oncological safety remains debatable [21,22,23]. If there are contraindications to MGT or a woman refuses it, it is a serious problem to provide effective medical
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
